Generic Methylin Oral Solution Approved

7/28/2010

The FDA has approved Tris Pharma’s methylphenidate hydrochloride oral solution, the first generic equivalent of Shionogi Pharma’s Methylin oral solution, indicated for the treatment of attention deficit disorders and narcolepsy.

Clin-eguide™ is an online clinical decision support tool that provides the most accurate evidence-based information for health care providers in the clinical setting. It integrates trusted content from Ovid, Facts & Comparisons®, and Lippincott Williams and Wilkins, as well as other premier publishers.